🔎 Trials Near Me

Akèy › Inkontinans Ijinè

Etid klinik pou Inkontinans Ijinè ap rekrite nan Etazini

13 etid pou Inkontinans Ijinè ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07456865

PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06789406

Aquarius Pilot Study to Evaluate the New Axonics Trial System

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07335484

Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer

Ap rekriteFaz 2
Laj 18 a 120 · Gason · Mizajou Jul 24, 2026 · NCT06161506

Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement

Ap rekrite
Laj 18 a 89 · Tout sèks · Mizajou Mar 6, 2026 · NCT04527445

TReating Incontinence for Underlying Mental and Physical Health

Ap rekriteFaz 4Volontè an sante akeyi
Laj 60 ak plis · Fanm · Mizajou Mar 6, 2026 · NCT05362292

Study of 30-Minute Stimulation With the Neuspera Sacral Neuromodulation (SNM) System

Ap rekrite
Laj 22 ak plis · Tout sèks · Mizajou Mar 5, 2026 · NCT07247136

Percutaneous Nerve Evaluation Trial Time

Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Fanm · Mizajou Feb 9, 2026 · NCT06226220

Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women

Ap rekrite
Laj 22 a 80 · Fanm · Mizajou Jan 30, 2026 · NCT07209397

A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jan 28, 2026 · NCT05685433

APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women

Ap rekrite
Laj 22 ak plis · Fanm · Mizajou Oct 27, 2025 · NCT06797245

Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections

Ap rekriteEtid obsèvasyonMande peman pou patisipan yo
Laj 55 ak plis · Fanm · Mizajou Sep 12, 2025 · NCT07025044

Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A

Ap rekriteFaz 4
Laj 18 ak plis · Fanm · Mizajou Nov 5, 2020 · NCT04305743

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.